United Health Products, Inc. (UEEC)
USD 0.23
(-5.7%)
USD 0.23
(-5.7%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -4857.00 USD | -125.76% |
| 2022 | 18.85 Thousand USD | 55358.82% |
| 2021 | 34.00 USD | -92.41% |
| 2020 | 448.00 USD | -87.59% |
| 2019 | 3611.00 USD | 107.1% |
| 2018 | -50.83 Thousand USD | -108.79% |
| 2017 | 578.63 Thousand USD | 366.36% |
| 2016 | 124.07 Thousand USD | 381.77% |
| 2015 | 25.75 Thousand USD | -67.69% |
| 2014 | 79.71 Thousand USD | 2505.03% |
| 2013 | 3060.00 USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 12.62 Thousand USD | 73.84% |
| 2009 | 7262.00 USD | -11.33% |
| 2008 | 8190.00 USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -1358.00 USD | -125.65% |
| 2024 Q2 | -1245.00 USD | 8.32% |
| 2023 FY | -4857.00 USD | -125.76% |
| 2023 Q1 | -1012.00 USD | -105.42% |
| 2023 Q2 | -1013.00 USD | -0.1% |
| 2023 Q3 | -1359.00 USD | -34.16% |
| 2023 Q4 | 5295.00 USD | 489.62% |
| 2022 Q4 | 18.66 Thousand USD | -1.03% |
| 2022 Q1 | -1012.00 USD | -1104.76% |
| 2022 Q2 | -1013.00 USD | -0.1% |
| 2022 Q3 | 18.85 Thousand USD | 1961.4% |
| 2022 FY | 18.85 Thousand USD | 55358.82% |
| 2021 Q1 | 34.00 USD | -57.5% |
| 2021 FY | 34.00 USD | -92.41% |
| 2021 Q4 | -84.00 USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2020 FY | 448.00 USD | -87.59% |
| 2020 Q4 | 80.00 USD | -21.57% |
| 2020 Q3 | 102.00 USD | 27.5% |
| 2020 Q2 | 80.00 USD | -56.99% |
| 2020 Q1 | 186.00 USD | 100.89% |
| 2019 FY | 3611.00 USD | 107.1% |
| 2019 Q1 | - USD | 100.0% |
| 2019 Q4 | -20.89 Thousand USD | 0.0% |
| 2019 Q3 | - USD | -100.0% |
| 2019 Q2 | 15.12 Thousand USD | 0.0% |
| 2018 FY | -50.83 Thousand USD | -108.79% |
| 2018 Q4 | -77.51 Thousand USD | -1492.21% |
| 2018 Q1 | 21.05 Thousand USD | -92.98% |
| 2018 Q2 | 60.00 USD | -99.71% |
| 2018 Q3 | 5568.00 USD | 9180.0% |
| 2017 Q4 | 300.05 Thousand USD | 547.96% |
| 2017 Q3 | 46.3 Thousand USD | 125.64% |
| 2017 Q2 | 20.52 Thousand USD | -90.31% |
| 2017 FY | 578.63 Thousand USD | 366.36% |
| 2017 Q1 | 211.74 Thousand USD | 135.6% |
| 2016 Q1 | 14.68 Thousand USD | 1044.0% |
| 2016 Q3 | 6845.00 USD | -45.96% |
| 2016 Q4 | 89.87 Thousand USD | 1213.0% |
| 2016 FY | 124.07 Thousand USD | 381.77% |
| 2016 Q2 | 12.66 Thousand USD | -13.77% |
| 2015 Q1 | 4847.00 USD | 120.3% |
| 2015 FY | 25.75 Thousand USD | -67.69% |
| 2015 Q4 | 1284.00 USD | -87.29% |
| 2015 Q3 | 10.1 Thousand USD | 6.09% |
| 2015 Q2 | 9521.00 USD | 96.43% |
| 2014 Q2 | - USD | -100.0% |
| 2014 Q4 | -23.87 Thousand USD | -1573.58% |
| 2014 Q3 | 1620.00 USD | 0.0% |
| 2014 FY | 79.71 Thousand USD | 2505.03% |
| 2014 Q1 | 103.58 Thousand USD | 3485.16% |
| 2013 Q2 | 1440.00 USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | -3060.00 USD | -288.89% |
| 2013 Q3 | 1620.00 USD | 12.5% |
| 2013 FY | 3060.00 USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q1 | - USD | 100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q4 | -32.08 Thousand USD | -377.56% |
| 2010 Q3 | -6719.00 USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2010 Q1 | 19.34 Thousand USD | 166.35% |
| 2010 FY | 12.62 Thousand USD | 73.84% |
| 2009 Q1 | - USD | -100.0% |
| 2009 FY | 7262.00 USD | -11.33% |
| 2009 Q4 | 7262.00 USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | 8190.00 USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | 8190.00 USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | 100.286% |
| Ansell Limited | 624.8 Million USD | 100.001% |
| Ansell Limited | 624.8 Million USD | 100.001% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 113.94 Million USD | 100.004% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | 103.596% |
| Psykey, Inc. | 415.97 Thousand USD | 101.168% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.17 Billion USD | 100.0% |
| Encision Inc. | 3.13 Million USD | 100.155% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | - USD | Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | 100.612% |
| LifePoint, Inc. | -71.35 Thousand USD | 93.193% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 96.292% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | 100.925% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | 100.805% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | 100.814% |
| SmileDirectClub, Inc. | 275.84 Million USD | 100.002% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 100.001% |
| SheerVision, Inc. | 2.17 Million USD | 100.223% |
| Vasamed, Inc. | -69.38 Thousand USD | 93.0% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | 101.815% |
| Yubo International Biotech Limited | 52.65 Thousand USD | 109.225% |